Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $41.3 Million - $46.1 Million
410,047 Added 16.5%
2,894,590 $301 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $272 Million - $301 Million
2,484,543 New
2,484,543 $282 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $229 Million - $250 Million
-2,183,109 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $25.4 Million - $30.8 Million
-277,050 Reduced 11.26%
2,183,109 $238 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $42 Million - $53.7 Million
-548,417 Reduced 18.23%
2,460,159 $225 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $26 Million - $38 Million
-414,197 Reduced 12.1%
3,008,576 $237 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $9.82 Million - $10.9 Million
-125,052 Reduced 3.52%
3,422,773 $297 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $39.9 Million - $43.2 Million
487,023 Added 15.91%
3,547,825 $297 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $6.67 Million - $7.78 Million
-91,577 Reduced 2.91%
3,060,802 $257 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $4.6 Million - $5.56 Million
-69,441 Reduced 2.16%
3,152,379 $252 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $211 Million - $239 Million
3,221,820 New
3,221,820 $233 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $683,931 - $754,855
-11,880 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $88,906 - $100,519
-1,580 Reduced 11.74%
11,880 $712,000
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $722,532 - $773,546
13,460
13,460 $768,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.